Predict your next investment

Adastra Pharmaceuticals company logo
HEALTHCARE | Drug Development
adastrarx.com

See what CB Insights has to offer

Founded Year

2005

Stage

Series E - II | Alive

Total Raised

$90.65M

Last Raised

$1.4M | 2 yrs ago

About Adastra Pharmaceuticals

Adastra Pharmaceuticals is a private, clinical-stage biopharmaceutical company committed to providing responsible solutions to advance patient care in oncology. Its vision is to identify, develop, and deliver to patients important new therapies for diseases with significant unmet needs. This commitment is epitomized by its lead clinical candidate, zotiraciclib, which is initially being developed for the treatment of high-grade gliomas (HGG) and diffuse intrinsic pontine glioma (DIPG), two forms of brain cancer characterized by Myc overexpression. Adastra possesses a rich history of institutional and academic collaboration, including ongoing clinical research programs with the National Cancer Institute (NCI) and the European Organisation for Research and Treatment of Cancer (EORTC).

Adastra Pharmaceuticals Headquarter Location

202 Carnegie Center Suite 104

Princeton, New Jersey, 08540,

United States

760-208-6900

Latest Adastra Pharmaceuticals News

Cothera Bioscience Acquires Zotiraciclib from Adastra Pharmaceuticals

Oct 6, 2021

Cothera to Advance Clinical Development of Oral Kinase Inhibitor with Unique Myc Depletion I want to thank all the physicians and dedicated healthcare providers who have put forward relentless effort on behalf of their patients as the Adastra team transitions zotiraciclib into Cothera.” — Scott Megaffin, Chief Executive Officer, Adastra PRINCETON, NEW JERSEY, USA, October … Continue reading "Cothera Bioscience Acquires Zotiraciclib from Adastra Pharmaceuticals"

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Adastra Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Adastra Pharmaceuticals is included in 2 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Adastra Pharmaceuticals Patents

Adastra Pharmaceuticals has filed 4 patents.

The 3 most popular patent topics include:

  • Experimental cancer drugs
  • Transcription factors
  • Acute myeloid leukemia
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/12/2020

11/16/2021

Transcription factors, Brain tumor, Oncology, Radiation therapy, Experimental cancer drugs

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

8/12/2020

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/16/2021

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Transcription factors, Brain tumor, Oncology, Radiation therapy, Experimental cancer drugs

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Adastra Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Adastra Pharmaceuticals Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.